Infectious disease testing remains the largest application segment for immunoassay analyzers. These systems are used to detect antigens and antibodies for conditions ranging from HIV and Hepatitis to emerging respiratory viruses. The ability to perform rapid, high-volume screening is a pillar of public health, allowing for effective contact tracing and epidemic management.

How are immunoassay systems adapting to antimicrobial resistance (AMR)?

The AMR crisis requires diagnostic tools that can quickly differentiate between viral and bacterial pathologies. Immunoassay analyzers are being used to measure procalcitonin (PCT) and C-reactive protein (CRP) levels, helping clinicians decide whether antibiotics are necessary. This data-driven approach to prescribing is essential for preserving the efficacy of existing pharmaceutical interventions.

Why are Infectious Disease Diagnostic Systems critical for 2024?

Advanced Infectious Disease Diagnostic Systems are now incorporating "syndromic" testing capabilities. In 2024, the trend is toward panels that test for a suite of pathogens simultaneously. This is vital in a globalized world where a patient presenting with a fever could have anything from seasonal flu to a tropical disease like Dengue or Zika.

2025 Market Outlook

In 2025, we anticipate the integration of environmental DNA (eDNA) monitoring with clinical immunoassay platforms. This "One Health" approach will allow public health officials to correlate viral loads in wastewater with clinical diagnostic data, providing a more comprehensive view of community health.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com